scispace - formally typeset
G

Guido Kroemer

Researcher at Institut Gustave Roussy

Publications -  1546
Citations -  294816

Guido Kroemer is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Programmed cell death & Apoptosis. The author has an hindex of 236, co-authored 1404 publications receiving 246571 citations. Previous affiliations of Guido Kroemer include Karolinska Institutet & Spanish National Research Council.

Papers
More filters
Journal ArticleDOI

Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma.

TL;DR: In this article, the effects of rapamycin on the mTOR signaling pathway, cell cycle control and apoptosis were studied before and after drug exposure by RT-PCR, and the results indicated that baseline Bcl-2 expression and therapy-induced downexpression of CCND1 and CDK4 may be regarded as molecular markers enabling the prediction and follow-up of the cellular effects on cell cycle.
Journal ArticleDOI

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy

TL;DR: Clinical findings that have been published during the last 13 months as well as clinical trials that have be launched in the same period to investigate the therapeutic profile of hitherto investigational tumor-targeting mAbs are discussed.